← Back to headlines
Arbutus Biopharma Reports Q1 Financial Results, Beats Revenue Estimates
Arbutus Biopharma reported GAAP EPS of -$0.17, missing estimates by $0.13, but revenue of $14.08 million significantly beat estimates by $13.47 million.
23 Mar, 11:34 — 23 Mar, 11:34
Sources
Showing 1 of 1 sources
